Recall D-0388-2026

US Class I Ongoing · initiated 2025-10-20

Recalling firm

ANTHONY TRINH, 123Herbals LLC, CA

Product

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

Reason for recall

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

← All recalls